World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26348
World Ranking
15075
National Ranking
1392

Seiichiro Yamamoto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Seiichiro Yamamoto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 358 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Seiichiro Yamamoto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Seiichiro Yamamoto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Seiichiro Yamamoto is affiliated with the National Cancer Research Institute in the United Kingdom. Their research primarily focuses on medicine, with extensive work in oncology, surgery, and pulmonary and respiratory medicine. The scientist's contributions span a total of 202 publications, with substantial involvement in specialized subfields such as oncology with 90 publications, surgery with 57, and pulmonary and respiratory medicine with 24.

Their research addresses a range of topics, notably in colorectal cancer surgical treatments, colorectal cancer screening and detection, colorectal and anal carcinomas, and gastric cancer management and outcomes. Additional areas of focus include inflammatory biomarkers in disease prognosis, esophageal and gastrointestinal pathology, and neuroendocrine tumor research advances.

Frequent publication venues for Seiichiro Yamamoto include:

  • Annals of Gastroenterological Surgery
  • Research Square
  • The Japanese Journal of Gastroenterological Surgery
  • Oncology
  • Annals of Surgical Oncology

Frequent co-authors collaborating with Yamamoto include Tomonori Akagi, Masafumi Inomata, Takeshi Naitoh, Hiroshi Miyakita, and Yoshiharu Sakai.

Notable recent papers featuring Seiichiro Yamamoto's work include:

  • Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma, 2021, Gastroenterology
  • Clinical impact of Endoscopic Surgical Skill Qualification System (ESSQS) by Japan Society for Endoscopic Surgery (JSES) for laparoscopic distal gastrectomy and low anterior resection based on the National Clinical Database (NCD) registry, 2020, Annals of Gastroenterological Surgery
  • Clinical impact of D3 lymph node dissection with left colic artery (LCA) preservation compared to D3 without LCA preservation: Exploratory subgroup analysis of data from JCOG0404, 2020, Annals of Gastroenterological Surgery
  • Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma: case report and literature review, 2021, World Journal of Surgical Oncology
  • Characteristics of anal canal cancer in Japan, 2022, Cancer Medicine

Best Publications

  • Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer

    Kazumasa Noda;Yutaka Nishiwaki;Masaaki Kawahara;Shunichi Negoro

  • D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

    Mitsuru Sasako;Takeshi Sano;Seiichiro Yamamoto;Yukinori Kurokawa

  • Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

    Toshimi Takano;Yuichiro Ohe;Hiromi Sakamoto;Koji Tsuta

  • Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501

    Takeshi Sano;Mitsuru Sasako;Seiichiro Yamamoto;Atsushi Nashimoto

  • Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

    Hirokazu Okayama;Takashi Kohno;Yuko Ishii;Yoko Shimada

  • Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.

    Narikazu Boku;Seiichiro Yamamoto;Haruhiko Fukuda;Kuniaki Shirao

  • Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)

    Atsushi Ohtsu;Yasuhiro Shimada;Kuniaki Shirao;Narikazu Boku

  • Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial

    Noriaki Ohuchi;Akihiko Suzuki;Tomotaka Sobue;Masaaki Kawai

  • Soy, Isoflavones, and Breast Cancer Risk in Japan

    Seiichiro Yamamoto;Tomotaka Sobue;Minatsu Kobayashi;Satoshi Sasaki

  • Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.

    Mitsuru Sasako;Takeshi Sano;Seiichiro Yamamoto;Motonori Sairenji

  • Risks and benefits of phase 1 oncology trials, 1991 through 2002.

    Elizabeth Horstmann;Mary S. McCabe;Louise Grochow;Seiichiro Yamamoto

  • Short-term Surgical Outcomes From a Randomized Controlled Trial to Evaluate Laparoscopic and Open D3 Dissection for Stage Ii/iii Colon Cancer: Japan Clinical Oncology Group Study Jcog 0404

    Seiichiro Yamamoto;Masafumi Inomata;Hiroshi Katayama;Junki Mizusawa

  • Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.

    Takeshi Sano;Mitsuru Sasako;Junki Mizusawa;Seiichiro Yamamoto

  • Phase II Study of Cisplatin and 5-Fluorouracil with Concurrent Radiotherapy in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516)

    Kaoru Ishida;Nobutoshi Ando;Seiichiro Yamamoto;Hiroko Ide

  • Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

    Seigo Kitano;Masafumi Inomata;Junki Mizusawa;Hiroshi Katayama

  • EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

    Toshimi Takano;Tomoya Fukui;Yuichiro Ohe;Koji Tsuta

  • Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

    T Yoshikawa;M Sasako;S Yamamoto;T Sano

  • MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening

    Yoshikatsu Koga;Masahiro Yasunaga;Amane Takahashi;Junichiro Kuroda

  • Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis

    Takehiko Yokobori;Hisae Iinuma;Teppei Shimamura;Seiya Imoto

  • Randomized controlled trial of laparoscopic versus open colectomy for advanced colorectal cancer

    H. Hasegawa;Y. Kabeshima;M. Watanabe;S. Yamamoto

Frequent Co-Authors

Shoichiro Tsugane
Shoichiro Tsugane International University of Health and Welfare
Masaki Kitajima
Masaki Kitajima Keio University
Manami Inoue
Manami Inoue National Cancer Centre
Motoki Iwasaki
Motoki Iwasaki National Cancer Research Institute, UK
Mitsuru Sasako
Mitsuru Sasako Hyogo College of Medicine
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital
Masaaki Ito
Masaaki Ito Mie University
Kenichi Sugihara
Kenichi Sugihara Tokyo Medical and Dental University
Satoshi Sasaki
Satoshi Sasaki University of Tokyo
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Medicine opens doors to diverse online degree options and career routes beyond the traditional MD program. For those interested in hospital administration, pursuing a masters in healthcare administration cost can be cost-effective and lead to vital non-clinical roles within healthcare systems.

Nurses aiming to upgrade their qualifications can find opportunities with the cheapest dnp programs, providing a pathway to advanced practice or leadership positions in nursing. Additionally, those interested in the pharmaceutical sector might consider an online pharmacy degree, which enables distance learners to prepare for rewarding careers as licensed pharmacists.

If you’re starting earlier, the best online schools for high school students offer programs that can lay the foundation for future study in health information management and data-driven fields.

Online degrees offer both flexibility and affordability, making them a practical choice for aspiring healthcare professionals across a range of career pathways.

Best Scientists Citing Seiichiro Yamamoto

Trending Scientists

Recently Published Articles